TYVASO DPI IS NOW APPROVED

TYVASO DPI
PAH TREATMENT IN THE
PALM OF YOUR HAND

hand holding TYVASO DPI inhaler

Taking a dose is as simple as:
JUST ONE BREATH—OPEN, LOAD, INHALE

TYVASO and TYVASO DPI are approved for the treatment
of pulmonary arterial hypertension (PAH; WHO Group 1)
to improve the ability to exercise.

WHY TYVASO?

TYVASO is inhaled directly to the lungs, where it’s needed—and may give you the ability to walk farther and do more of what matters most to you. TYVASO is offered in 2 delivery options, including a dry powder inhaler (DPI) and a nebulizer.

CO-PAY ASSISTANCE PROGRAM

With the TYVASO Co-Pay Assistance Program, most eligible patients pay as little as a $0 co-pay for each prescription of TYVASO or TYVASO DPI.

bubbles for design
quotes icon
I hope TYVASO will help you as it's helped me.

TYVASO Patient
Individual results may vary.